Marinol (dronabinol)

DRUG2 trials

Sponsors

Brigham and Women's Hospital, Alberta Health services

Conditions

AnorexiaCancerChronic PainOlfactory DisordersTaste Disorders

Phase 2

Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain

CompletedNCT00153192

Brigham and Women's HospitalChronic Pain

Start: 2001-04-30End: 2006-04-30Target: 30Updated: 2013-04-26

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

CompletedNCT00316563

Alberta Health servicesAnorexia, Cancer, Olfactory Disorders +1

Start: 2006-08-31End: 2009-11-30Target: 80Updated: 2010-02-09

Related Papers

Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial.

2011-02-22149 citations